Maribavir - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Maribavir

Brand Name:

Livtencity

Strength:

200mg

HCPCS:

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Miscellaneous Agent

Minor Drug Class:

CMV Antiviral

Oral (Y/N):

Yes

FDA Approval Year:

2021

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use